Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

AlphaHelix Molecular Diagnostics AB (ALHX)

Spotlight
Currency in SEK
Disclaimer
0.2720
0.0000(0.00%)
Delayed Data
ALHX Scorecard
Fair Value
Unlock Value
Day's Range
0.27200.2720
52 wk Range
0.19900.7900
Prev. Close
0.284
Open
0.272
Day's Range
0.272-0.272
52 wk Range
0.199-0.79
Volume
0
Average Volume (3m)
44,212
1-Year Change
-63.54%
Shares Outstanding
63,398,901
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about ALHX?
Vote to see community's results!
or

AlphaHelix Molecular Company Profile

AlphaHelix Molecular Diagnostics AB (publ) designs, develops, and distributes diagnostics products in the Nordic region and internationally. The company distributes equipment; consumables and reagents for molecular biology; and research and diagnostic products in Sweden and the Nordics. It also develops, produces, and sells products for genetic fetal diagnostics, as well as genetic miscarriage and infertility diagnostics products. In addition, the company engages in the development of products for congenital heart defect. Its product portfolio includes Rob, an automated 96/384 qPCR setup; BugScreener, a system for screening methicillin resistant staphylococcus aures; and aAmp, a thermal cycler that utilizes SuperConvection technology, which enables accurate PCR assays. The company was incorporated in 1998 and is headquartered in Stockholm, Sweden.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.